Polymorphic forms of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoylbenzofuran-5-yl) piperazine hydrochloride | Patent Number 08673921

US 08673921 B2
Application Number14032183
Publication NumberUS 20140024658 A1
Pendency6 months
Filled DateSep 19, 2013
Priority DateJun 5, 2002
Publication DateJan 23, 2014
Expiration DateJun 5, 2022
Inventor/ApplicantsSusanne Rudolph
Andreas Bathe
Henning Bottcher
Steffen Neuenfeld
Matthias Bartels
Bernd Helfert
Heike Kniel
ExaminesSHTERENGARTS, SAMANTHA L
Art Unit1626
Technology Center1600
Assignments
Merck Patentgesellschaft
Current
Merck PatentgesellschaftMerck & Co. Inc.
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.